Company: LLOBF
Filing Date: 2025-02-25
Form Type: 424B2
Source: 0000950103-25-002401
Chunk: 17

Company: Lloyds Banking Group plc
Filing Date: 2025-02-25
Form: 424B2
Chunk 17
---
), whether or not specifically mentioned in this prospectus supplement, including (without limitation)
any requirements under MiFID II, the FCA Handbook, the HKMA Circular or any other applicable laws, regulations and regulatory guidance
as to determining the appropriateness and/or suitability of an investment in the Additional Tier 1 Securities (or any beneficial interests
therein) for investors in any relevant jurisdiction.

<div align='center'>NOTICE TO CANADIAN
INVESTORS</div>

The Additional Tier 1 Securities
may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined
in National Instrument 45-106 Prospectus Exemptions (“NI 45-106”) or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations (“NI 31-103”) and that are not created or used solely to purchase or hold securities as
an accredited investor described in paragraph (m) of the definition of “accredited investor”.

The offer and sale of the
Additional Tier 1 Securities in Canada is being made on a private placement basis only and is exempt from the requirement that we prepare
and file a prospectus under applicable Canadian securities laws. Any resale of the Additional Tier 1 Securities must be made in accordance
with applicable Canadian securities laws, which may vary depending on the relevant jurisdiction, and which may require resales to be made
in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws. These
resale restrictions may under certain circumstances apply to resales of the Additional Tier 1 Securities outside of Canada.

Securities legislation in
certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus supplement
or the accompanying prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission
or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser’s province
or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser’s province
or territory for the particulars of these rights or consult with a legal advisor.

Pursuant to section 3A.3
of National Instrument 33-105 Underwriting Conflicts (“NI 33-105”), the Underwriters